|
Name |
Agarospirol
|
Molecular Formula | C15H26O | |
IUPAC Name* |
2-[(3R,5R,6R)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol
|
|
SMILES |
C[C@@H]1CCC=C([C@@]12CC[C@H](C2)C(C)(C)O)C
|
|
InChI |
InChI=1S/C15H26O/c1-11-6-5-7-12(2)15(11)9-8-13(10-15)14(3,4)16/h6,12-13,16H,5,7-10H2,1-4H3/t12-,13-,15+/m1/s1
|
|
InChIKey |
ICWHTQRTTHCUHW-NFAWXSAZSA-N
|
|
Synonyms |
Agarospirol; 1460-73-7; 2-[(3R,5R,6R)-6,10-dimethylspiro[4.5]dec-9-en-3-yl]propan-2-ol; (-)-Agarospirol; 2-(6,10-Dimethylspiro[4.5]dec-6-en-2-yl)-2-propanol #; CHEBI:167410; alpha,alpha,6,10-Tetramethylspiro(4.5)dec-6-ene-2-methanol; Spiro(4.5)dec-6-ene-2-methanol, alpha,alpha,6,10-tetramethyl-
|
|
CAS | 1460-73-7 | |
PubChem CID | 21675005 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 222.37 | ALogp: | 3.7 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 16 | QED Weighted: | 0.644 |
Caco-2 Permeability: | -4.466 | MDCK Permeability: | 0.00001830 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.049 |
30% Bioavailability (F30%): | 0.016 |
Blood-Brain-Barrier Penetration (BBB): | 0.196 | Plasma Protein Binding (PPB): | 98.35% |
Volume Distribution (VD): | 1.537 | Fu: | 2.34% |
CYP1A2-inhibitor: | 0.14 | CYP1A2-substrate: | 0.725 |
CYP2C19-inhibitor: | 0.285 | CYP2C19-substrate: | 0.896 |
CYP2C9-inhibitor: | 0.324 | CYP2C9-substrate: | 0.812 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.493 |
CYP3A4-inhibitor: | 0.177 | CYP3A4-substrate: | 0.197 |
Clearance (CL): | 6.504 | Half-life (T1/2): | 0.243 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.077 |
Drug-inuced Liver Injury (DILI): | 0.047 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.032 | Maximum Recommended Daily Dose: | 0.193 |
Skin Sensitization: | 0.925 | Carcinogencity: | 0.102 |
Eye Corrosion: | 0.987 | Eye Irritation: | 0.985 |
Respiratory Toxicity: | 0.242 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003101 | 0.712 | D07QKN | 0.389 | ||||
ENC000860 | 0.391 | D04SFH | 0.220 | ||||
ENC001830 | 0.387 | D0SC8F | 0.212 | ||||
ENC000511 | 0.385 | D0I2SD | 0.207 | ||||
ENC002195 | 0.375 | D04GJN | 0.207 | ||||
ENC004617 | 0.375 | D08IWD | 0.206 | ||||
ENC002248 | 0.375 | D02VPX | 0.206 | ||||
ENC001013 | 0.365 | D0B4RU | 0.202 | ||||
ENC002138 | 0.355 | D05BTM | 0.202 | ||||
ENC001832 | 0.355 | D0N1TP | 0.202 |